Camp4 Therapeutics CAMP
NASDAQ CAMP
$3.84 -0.20 (-4.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Net Equity Issued and Repurchased (2023 - 2025)

Updated

Camp4 Therapeutics' Net Equity Issued and Repurchased came in at $24.95 million for Q4 2025, down 67.3% from $76.32 million a year earlier and down 23.4% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

For FY2025, Camp4 Therapeutics' Net Equity Issued and Repurchased was $57.52 million, down 24.7% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $76.35 million in FY2024 and $185,000 in FY2023.
  • The Q4 2025 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Camp4 Therapeutics 209.79 Mn 209.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 24.95 Mn
Sep 30, 2025 32.56 Mn
Dec 31, 2024 76.32 Mn
Sep 30, 2024 31,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 173,000.00
API Access

Camp4 Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CAMP&period=max&api_key=YOUR_API_KEY